Business Insights

Emerging and disruptive technologies driving personalized medicine

Life Sciences

In Vitro Diagnostics

Business Insights’ IVD research stream provides in-depth analysis of the most commercially significant new technologies in in vitro diagnostics, including the role they play in driving future market growth for both the diagnostic and pharmaceutical industries.

The diagnostic and pharmaceutical industries are becoming increasingly integrated because the development of personalized medicine is dependent upon rapid diagnosis at the point of care. With increasing numbers of biomarkers being validated, pharmaceutical companies are collaborating with the diagnostics industry to develop new diagnostic tests that work specifically for their drugs.

At the same time, new biologics are becoming more targeted to specific sub-diseases, so accurate patient diagnosis to ensure effective treatment also becomes critical.

The impact of new diagnostic technologies on drug development

In Vitro Diagnostics reports

These are our most recently published In Vitro Diagnostics reports. To view all the reports we publish on this subject please visit our Store or existing users can access them via their Interactive service.